Latest APRE reports update at 2024-05-14: 2024-Q12023-Q42023-Q1
Aprea Therapeutics logo
Aprea Therapeutics APRE
$ 5.5 7.11%

Aprea Therapeutics EV - Enterprise Value 2011-2024 | APRE

Annual EV - Enterprise Value Aprea Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-191 K -21.3 M -50 M -68.4 M 103 M 51.8 M 36.1 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
103 M -68.4 M 7.25 M